Insider Selling: Alignment Healthcare, Inc. (NASDAQ:ALHC) CFO Sells 30,500 Shares of Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) CFO Robert Thomas Freeman sold 30,500 shares of the stock in a transaction on Monday, November 11th. The shares were sold at an average price of $13.42, for a total value of $409,310.00. Following the completion of the transaction, the chief financial officer now owns 92,929 shares of the company’s stock, valued at $1,247,107.18. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink.

Robert Thomas Freeman also recently made the following trade(s):

• On Thursday, October 31st, Robert Thomas Freeman sold 36,197 shares of Alignment Healthcare stock. The shares were sold at an average price of $12.04, for a total value of $435,811.88.
• On Tuesday, October 29th, Robert Thomas Freeman sold 4,483 shares of Alignment Healthcare stock. The shares were sold at an average price of $12.01, for a total value of $53,840.83.
• On Monday, October 14th, Robert Thomas Freeman sold 30,500 shares of Alignment Healthcare stock. The stock was sold at an average price of $11.50, for a total transaction of $350,750.00.
• On Tuesday, October 8th, Robert Thomas Freeman sold 39,320 shares of Alignment Healthcare stock. The shares were sold at an average price of $12.04, for a total transaction of $473,412.80.
• On Tuesday, October 1st, Robert Thomas Freeman sold 21,375 shares of Alignment Healthcare stock. The shares were sold at an average price of $10.66, for a total value of $227,857.50.
• On Friday, September 13th, Robert Thomas Freeman sold 14,500 shares of Alignment Healthcare stock. The stock was sold at an average price of $12.00, for a total value of $174,000.00.
• On Wednesday, September 11th, Robert Thomas Freeman sold 8,561 shares of Alignment Healthcare stock. The shares were sold at an average price of $10.01, for a total value of $85,695.61.
• On Wednesday, September 4th, Robert Thomas Freeman sold 1,650 shares of Alignment Healthcare stock. The stock was sold at an average price of $10.00, for a total value of $16,500.00.

Alignment Healthcare Stock Down 2.9 %

Shares of NASDAQ ALHC traded down $0.38 during midday trading on Wednesday, hitting $12.78. 934,105 shares of the stock traded hands, compared to its average volume of 1,045,498. Alignment Healthcare, Inc. has a one year low of $4.46 and a one year high of $14.25. The business has a 50 day moving average price of $11.43 and a two-hundred day moving average price of $9.26. The company has a debt-to-equity ratio of 1.82, a quick ratio of 1.60 and a current ratio of 1.60. The company has a market cap of $2.45 billion, a PE ratio of -16.60 and a beta of 1.45.

Alignment Healthcare (NASDAQ:ALHC) last released its quarterly earnings data on Tuesday, October 29th. The company reported ($0.14) earnings per share for the quarter, hitting the consensus estimate of ($0.14). The firm had revenue of $692.43 million for the quarter, compared to the consensus estimate of $662.11 million. Alignment Healthcare had a negative net margin of 5.84% and a negative return on equity of 108.69%. The business’s revenue was up 51.6% on a year-over-year basis. During the same quarter in the prior year, the company posted ($0.19) earnings per share. On average, equities analysts predict that Alignment Healthcare, Inc. will post -0.69 EPS for the current year.

Institutional Trading of Alignment Healthcare

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in ALHC. Creative Planning boosted its position in shares of Alignment Healthcare by 20.0% during the third quarter. Creative Planning now owns 12,442 shares of the company’s stock valued at $147,000 after buying an additional 2,072 shares during the last quarter. Principal Financial Group Inc. boosted its holdings in Alignment Healthcare by 18.1% during the 2nd quarter. Principal Financial Group Inc. now owns 13,521 shares of the company’s stock worth $106,000 after acquiring an additional 2,077 shares during the last quarter. Allspring Global Investments Holdings LLC grew its stake in shares of Alignment Healthcare by 9.2% in the 1st quarter. Allspring Global Investments Holdings LLC now owns 39,570 shares of the company’s stock worth $196,000 after acquiring an additional 3,334 shares in the last quarter. nVerses Capital LLC purchased a new stake in shares of Alignment Healthcare in the third quarter valued at about $95,000. Finally, The Manufacturers Life Insurance Company lifted its position in shares of Alignment Healthcare by 20.9% during the second quarter. The Manufacturers Life Insurance Company now owns 55,531 shares of the company’s stock valued at $434,000 after purchasing an additional 9,595 shares in the last quarter. 86.19% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on ALHC. KeyCorp assumed coverage on shares of Alignment Healthcare in a report on Friday, October 11th. They set a “sector weight” rating for the company. UBS Group boosted their target price on shares of Alignment Healthcare from $9.00 to $12.00 and gave the company a “neutral” rating in a report on Wednesday, October 30th. Barclays upped their price target on shares of Alignment Healthcare from $7.00 to $8.00 and gave the company an “underweight” rating in a research report on Wednesday, October 30th. TD Cowen lifted their price objective on Alignment Healthcare from $8.00 to $10.00 and gave the stock a “buy” rating in a research report on Tuesday, August 6th. Finally, Piper Sandler restated an “overweight” rating and set a $10.00 target price (up previously from $8.00) on shares of Alignment Healthcare in a research report on Tuesday, August 6th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, six have issued a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $10.33.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.